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Grade 1 (complete regression) showed an absence of histologi-
cally identifiable residual cancer and predominant fibrosis extend-
ing through the different layers of the rectal wall. Grade 2 (inter-
mediate regression) was characterized by an increase in the num-
ber of residual cancer cells, but still fibrosis was dominant. Grade 
3 (poor regression) showed residual cancer outgrowing fibrosis, a 
scant presence or a complete absence of regressive changes, and 
residual cancer cells.
In this study, the authors investigated the prognostic significance 
of a semi-quantitative grading system for tumor regression after 
preoperative CRT. First, the authors performed analyses for all 
patients and then for the subgroup of patients who had no lymph 
node metastasis (ypN0). The authors also investigated whether 
TRG had any correlation with the presence of metastatic lymph 
nodes or with histopathologic T- and N-downstagings. Finally, 
the authors investigated whether different prognoses were ob-
served among ypN0 patients with different TRGs given a specific 
ypTN stage or vice versa. The authors suggested in this study that 
TRG was found to have a limited prognostic significance follow-
ing preoperative chemoradiation therapy for the treatment of lo-
cally advanced rectal cancer. Although, as a whole, TRG had a 
weaker prognostic power than ypN stage, it was found to have the 
strongest prognostic power in the patients without lymph node 
metastasis. For better prediction of oncologic outcomes after pre-
operative chemoradiation therapy in locally advanced rectal can-
cer, tumor regression grade, in addition to ypT and ypN staging 
system, should be addressed.
If evaluation of TRG is to be implemented in pathologic reports, 
a standard method of assessing tumor response is clearly required. 
Although tumor regression grade basically scores the ratio of re-
sidual cancer cell to radiation-induced fibrosis, there is still no a 
standard method for scoring tumor regression grade. This is im-
portant because documentation of TRG may be different depend-
ing on the method of preparing slides, the number of slides re-
viewed per tumor, the experience of the reviewers, and so on. The 
three-point grade has the advantage of better reproducibility, with 
similar prognostic significance [5].
It is clear that there are multiple clinical and histopathological 
factors that are relevant in determining the prognosis after preop-
erative CRT. Long-term oncologic outcomes in patients with rec-
In recent years, a number of studies on the use of preoperative 
chemoradiotherapy (CRT) in patients with cT3-4 rectal cancer 
have reported a pathologically complete response rate of 9-29%, 
as well as an increased ability to perform sphincter-sparing sur-
gery [1, 2]. Preoperative CRT is superior to postoperative treat-
ment in terms of local control and toxicity [3]. In the Swedish 
Rectal Cancer Trial, the rate of local recurrence was 27% with sur-
gery alone, 20% with postoperative radiation (60 Gy in 8 weeks) 
and 11% with preoperative radiation (25 Gy in 5 fractions) [4]. 
There was also a significant improvement in the 5-year disease-
free survival rate, which was attributed to a lower rate of distant 
metastases, with preoperative radiation when compared to either 
surgery alone or surgery with postoperative radiation [4]. How-
ever, tumor response after preoperative CRT for rectal cancer var-
ies considerably. Recent studies have demonstrated that good re-
sponse to preoperative CRT is a favorable prognostic factor and 
that a high grade of tumor regression is indicative of better sur-
vival [5]. Therefore, the accurate evaluation of tumor response to 
preoperative CRT is suggested to be essential for predicting onco-
logic outcomes and for planning further treatment.
Regressive changes of the primary tumors in response to preop-
erative CRT were documented as described by Mandard et al. [6]. 
They first developed a five-point grading scale to assess the re-
sponse to preoperative CRT in esophageal cancer. However, only 
two groups of tumor regression grades (TRGs) were prognosti-
cally relevant (grades 1, 2, 3 vs. 4, 5). Rodel et al. [5] suggested that 
primary tumor regression was grouped into three categories: 
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tal cancer after preoperative CRT were found to depend on histo-
pathologic T and N downstaging and on tumor regression grade. 
However, TRG alone is not definitive for giving a prognosis. Well-
established histopathologic factors, in particular the ypT and ypN 
category, remain the most important prognostic factors [7]. Posi-
tive lymph nodes after preoperative CRT indicate both an aggres-
sive potential of the malignant cells in regional lymph nodes and 
a resistance of those cells to CRT. Thus, traditional histopathologic 
staging, especially N staging, remains the most important prognos-
tic factor for cancer-specific survival, and TRG may aid in deter-
mining a prognosis for patients, particularly those without lymph 
node metastasis. In patients who achieved N-downstaging after 
preoperative chemoradiation, an accurate prediction of cancer-
specific survival requires information on both the number of via-
ble cancer cells remaining (TRG) and whether or not the foci of 
viable cancer cells are located within or outside the rectal wall (ypT 
stage).
Tumor regression grade seems to be a prognostic factor for dis-
ease-free survival in patients receiving preoperative CRT for rectal 
cancer. In addition, it is a prognostic factor for local failure, me-
tastasis-free survival, and overall survival [8].
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